Showing results (1-10 of 155) with videos related to
Sort By:
Pageof 16
Therapeutic Advances in Hematology|March 28, 2022
Loncastuximab tesirine in relapsed or refractory diffuse large B-cell lymphoma: a review of clinical dataFateeha Furqan, Mehdi HamadaniExpert Opinion on Biological Therapy|June 2, 2022
Bispecific CAR T-cells for B-cell MalignanciesFateeha Furqan, Nirav N ShahAnnual Review of Medicine|November 4, 2022
Multispecific CAR T Cells Deprive Lymphomas of Escape via Antigen LossFateeha Furqan, Nirav N ShahClinical Advances in Hematology & Oncology : H&O|April 8, 2024
The role of noncovalent BTK inhibitors in the era of covalent BTK inhibitorsFateeha Furqan, Nirav N ShahCancer Metastasis Reviews|December 1, 2024
CAR T-cell therapy for B-cell lymphomas: outcomes and resistance mechanismsTyce J Kearl, Fateeha Furqan, Nirav N ShahExpert Review of Anticancer Therapy|May 29, 2024
Bispecific antibodies in the treatment of relapsed/refractory large B-cell lymphomaGulrayz Ahmed, Fateeha Furqan, Elham Nasrollahi, et al.Leukemia & Lymphoma|December 17, 2020
Expression of BCL2 alternative proteins and association with outcome in CLL patients treated with venetoclaxMario L Marques-Piubelli, Ellen J Schlette, Joseph D Khoury, et al.Mayo Clinic Proceedings|August 6, 2020
Prevalence and Mortality of COVID-19 Patients With Gastrointestinal Symptoms: A Systematic Review and Meta-analysisRaseen Tariq, Srishti Saha, Fateeha Furqan, et al.Drugs & Aging|May 6, 2019
Treating Older Patients with Chronic Lymphocytic Leukemia: A Personalized ApproachPaolo Strati, Alessandra FerrajoliFrontiers in Oncology|July 17, 2020
CAR T-Cell Therapy for B-Cell non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia: Clinical Trials and Real-World ExperiencesCandida Vitale, Paolo StratiPageof 16